• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Zafgen, Inc. (ZFGN)

    -NasdaqGS
    6.27 Down 0.43(6.42%) Feb 5, 4:00PM EST
    |After Hours : 6.27 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:6.70
    Open:6.69
    Bid:6.17 x 200
    Ask:7.77 x 3500
    1y Target Est:22.14
    Beta:N/A
    Earnings Date:Mar 17 - Mar 21 (Est.)
    Day's Range:6.21 - 6.77
    52wk Range:5.34 - 55.36
    Volume:693,163
    Avg Vol (3m):1,782,490
    Market Cap:170.76M
    P/E (ttm):N/A
    EPS (ttm):-2.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZFGNDown 6.42%170.76M
    JNJDown 3.23%278.19B
    BSXDown 4.15%22.36B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.71
    Quarterly EPS Est (Dec-15) :-0.80
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from obesity and obesity-related disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback